Results 101 to 110 of about 6,412,465 (299)
Nanobodies, derived from the variable domains of camelid heavy‐chain‐only antibodies, have emerged as transformative biomedical tools due to their nanoscale size, exceptional stability, and unique capacity to recognize cryptic epitopes. This review provides a comprehensive overview of the field, outlining the structural and biochemical features of ...
Zhenrui Ye, Xianyang Li, Meixiao Zhan
wiley +1 more source
Clinical utility of panel-based genetic sequencing for von Willebrand disease
Background: von Willebrand disease (VWD) is the most prevalent inherited bleeding disorder with a wide spectrum of causative variants. Next-generation sequencing analyzes the entire VWF gene and provides concomitant assessment of other genes, allowing ...
Radha Ramanan +12 more
doaj +1 more source
Safety of Recombinant von Willebrand Factor in the Treatment of von Willebrand Disease: Real-World Data from an EU Post-Authorization Safety Study [PDF]
Susan M Sinclair, Yi Ba, Kayode Badejo Takeda Development Center Americas, Inc., Cambridge, MA, USACorrespondence: Susan M Sinclair, Takeda Development Center Americas, Inc., 650 E Kendall Street, Cambridge, MA, 02142, USA, Email susan.sinclair@takeda ...
Sinclair SM, Ba Y, Badejo K
core
Dynamic immuno‐mechanobiomaterials with time‐programmed mechanical adaptation orchestrate host responses through precise mechanotransduction and immune‐stromal regulation. These adaptive biomaterials minimize mechanical mismatch, attenuate the forign dy response and fibrosis, promote angiogenesis and controlled extracellular matrix remodeling, and ...
Gobinath Vellapalayam Manoharan +4 more
wiley +1 more source
Reduction of high‐molecular‐weight von Willebrand factor disrupts the platelet–complement amplification loop, attenuating microvascular thrombosis, complement deposition, endothelial injury, and organ damage in complement‐mediated thrombotic microangiopathy.
Yang Li +17 more
wiley +1 more source
Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome. [PDF]
ABSTRACT Acquired von Willebrand Syndrome (AVWS) is a rare bleeding disorder characterized by quantitative or qualitative defects of von Willebrand factor (VWF) in patients without a personal or family history of bleeding. It is frequently associated with systemic diseases, particularly lymphoproliferative disorders (LPDs) and myeloproliferative ...
Ciavarella A +10 more
europepmc +2 more sources
An Automated Microfluidic System for Haemostasis Assessment in Cirrhosis With Thrombocytopenia. [PDF]
ABSTRACT Background & Aims Conventional laboratory tests do not capture platelet–vessel wall interactions (primary haemostasis) occurring in vivo, limiting guidance before invasive procedures. This is relevant in patients with thrombocytopenia, hallmark of advanced cirrhosis. Microfluidic assays may overcome these limitations.
Bitto N +14 more
europepmc +2 more sources
ABSTRACT Background A significant complication of pediatric tonsillectomy is post‐tonsillectomy bleeding (PTB). Management within and outside of the operating room (OR) is not standardized. We consolidated international similarities and differences in PTB management.
Gina M. Spencer +8 more
wiley +1 more source
Persistent Gingival Bleeding After Scaling: A Diagnostic Clue to von Willebrand Disease. [PDF]
ABSTRACT Von Willebrand disease (VWD) is not a rare inherited bleeding disorder. However, it is frequently underdiagnosed because early mucocutaneous bleeding manifestations are often attributed to local factors such as inflammation or anatomical abnormalities, leading to delayed recognition of the underlying systemic disease. A 31‐year‐old Han Chinese
Zhang H, Qiu N, Cao Z, Shang S.
europepmc +2 more sources
De ziekte van von Willebrand in Nederland: de WiN-studie
Von Willebrand disease is the most common inherited bleeding disorder and is characterised by mucocutaneous bleeding. Von Willebrand disease is caused by reduced levels or reduced function of von Willebrand factor.
Fijnvandraat, C. J. Karin +9 more
core

